JJ Duby, RK Campbell, SM Setter, JR White, … - American Journal of Health-System Pharmacy, 2004 - ASHP 160 Am J Health-Syst Pharm—Vol 61 Jan 15, 2004 ... J EREMIAH J OHN D UBY , R.
K EITH C AMPBELL , S TEPHEN M. S ETTER , ... J OHN R AYMOND W HITE , AND K
RISTIN A. R ASMUSSEN ... J EREMIAH J OHN D UBY , P HARM .D., is General ... Cited by 150 - Related articles - BL Direct - All 9 versions
- ►pubget.com [PDF] V Fonseca, A Seftel, J Denne, P Fredlund - Diabetologia, 2004 - Springer Aims/hypothesis. A retrospective analysis of pooled data from twelve
placebo-controlled trials was conduct- ed to characterise the efficacy and
safety of tadalafil for the treatment of erectile dysfunction in men with ... Cited by 81 - Related articles - All 4 versions
CC Carson, TF Lue - BJU International-British Journal of Urology, 2005 - bjui.org The cyclic nucleotide signalling pathway mediates the smooth-muscle relaxing
effects of nitric oxide necessary for normal erectile function. Down-regulation
of this pathway is central to the pathophysiology of many forms of erectile ... Cited by 74 - Related articles - BL Direct - All 5 versions
- ►dsb.ro [PDF] E Wespes, E Amar, D Hatzichristou, F Montorsi … - European urology, 2002 - Elsevier Male erectile dysfunction (ED) (impotence) has been defined as the persistent
(lasting for at least 6 months) inability to attain and maintain an erection
sufficient to permit satisfactory sexual performance. Although ED is a ... Cited by 71 - Related articles - BL Direct - All 28 versions
P Ströberg, A Murphy, T Costigan - Clinical therapeutics, 2003 - Elsevier Methods: This was a short-term, multicenter, open-label, 1-way crossover trial
conducted in Sweden and Italy. Eligible patients included men aged ≥18 years
with a minimum 3-month history of ED who had been taking sildenafil at ... Cited by 71 - Related articles - All 4 versions
J Angulo, P Cuevas, A Fernández, S Gabancho, … - Biochemical and Biophysical Research …, 2003 - Elsevier Standard treatments for erectile dysfunction (ED) (ie, PDE5 inhibitors) are less
effective in diabetic patients for unknown reasons. Endothelium-dependent
relaxation (EDR) of human corpus cavernosum (HCC) depends on nitric oxide ... Cited by 60 - Related articles - All 6 versions
C McMahon - The Journal of Sexual Medicine, 2004 - issir.com Page 1. Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction
previously unresponsive to “On Demand” Tadalafil Chris G McMahon ... Cited by 56 - Related articles - BL Direct - All 4 versions
C Stief, H Porst, I Saenz De Tejada, E Ulbrich … - International journal of clinical practice, 2004 - interscience.wiley.com This randomised, double-blind study assessed the long-term efficacy and
tolerability of vardenafil 10 and 20 mg in men with erectile dysfunction (ED). A
total of 566 men who completed an initial 12-month treatment period entered ... Cited by 60 - Related articles - BL Direct - All 5 versions
D Hatzichristou, F Montorsi, J Buvat, N … - European urology, 2004 - Elsevier Results: The IIEF-EF domain score significantly improved from a baseline of
moderate ED (12.6–13.1) to mild ED in men on vardenafil (21.0–24.2) compared
with placebo (13.7–15.6) at weeks 4, 8, 12, and last observation carried ... Cited by 57 - Related articles - All 3 versions
- ►diabetesjournals.org JS Brown, H Wessells, MB Chancellor, SS … - Diabetes care, 2005 - Am Diabetes Assoc Diabetes and urologic diseases are very common health problems that markedly
increase in prevalence and incidence with advancing age (1–3). Diabetes is
associated with an earlier onset and increased severity of urologic ... Cited by 52 - Related articles - All 5 versions
